As Chris Froome prepares for his next racing appearance of the season at Tirreno-Adriatico (March 7-13), a Freedom of Information request made by the Press Association to UK Anti-Doping (UKAD) has underlined the difficulties the British rider faces in defending himself against a doping charge resulting from the elevated level of salbutamol recorded following a stage of last year’s Vuelta a España.
According to PA’s FOI request, UKAD dealt with 109 adverse analytical findings (AAFs) between January 1, 2015 and December 31, 2017, of which 77 – a little more than 70 per cent – resulted in an anti-doping rule violation (ADRV).
More pertinently, the FOI request revealed that although only three of these AAFs were for salbutamol, all three of these cases resulted in an ADRV.
>>> Everything you need to know about Chris Froome's salbutamol case
UKAD’s stats for the number of AAFs that result in an ADRV are very much in line with those for the World Anti-Doping Agency (WADA).
Its last report for 2015, which was published in April 2017 and is the latest available, reveals that during that year there were 244 AAFs in cycling, of which 144 ultimately resulted in an ADRV.
Watch: Which is the fastest cycling position?
http://www.youtube.com/watch?v=MVxK9VVOkQY
WADA’s report breaks down the 100 AAFs that didn’t result in an ADRV into four categories: 46 were cleared for medical reasons, 21 had no case to answer, 11 received no sanction, while 22 were pending and will, presumably, be detailed in WADA’s 2016 report, which is due for publication next month.
Froome has denied breaking anti-doping rules which allow athletes to take a maximum of 800mg of salbutamol per 12 hours, and, with Team Sky's backing, has vowed to clear his name.
>>> Team Sky reveal line-up for Paris-Nice: Sergio Henao and Wout Poels joint leaders
Contacted by PA, the UCI said it had “no update” on Froome’s case. The Team Sky leader has been confirmed by Tirreno organisers RCS as one of the star attractions for “the race of the two seas”, which will also feature Tom Dumoulin, Romain Bardet, Vincenzo Nibali, Richie Porte and Mikel Landa among its GC big hitters.
Following Tirreno, Froome’s is set to race the Tour of the Alps in mid-April before targeting the Giro d’Italia title in May.
